The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
Open accessAbstract
The main protease of coronaviruses and the 3C protease of enteroviruses share a similar active-site architecture and a unique requirement for glutamine in the P1 position of the substrate. Because of their unique specificity and essential role in viral polyprotein processing, these proteases are suitable targets for the development of antiviral drugs. In order to obtain near-equipotent, broad-spectrum antivirals against alphacoronaviruses, betacoronaviruses, and enteroviruses, we pursued a structure-based design of peptidomimetic α-ketoamides as inhibitors of main and 3C proteases. Six crystal structures of protease–inhibitor complexes were determined as part of this study. Compounds synthesized were tested against the recombinant proteases as well as in viral replicons and virus-infected cell cultures; most of them were not cell-toxic. Optimization of the P2 substituent of the α-ketoamides proved crucial for achieving near-equipotency against the three virus genera. The best near-equipotent inhibitors, 11u (P2 = cyclopentylmethyl) and 11r (P2 = cyclohexylmethyl), display low-micromolar EC50 values against enteroviruses, alphacoronaviruses, and betacoronaviruses in cell cultures. In Huh7 cells, 11r exhibits three-digit picomolar activity against the Middle East Respiratory Syndrome coronavirus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
Overview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353
REFMAC 5 for the refinement of macromolecular crystal structures
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F., & Vagin, A. A. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911001314 · Cited by 8,317
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Molecular replacement with MOLREP
Vagin, A., & Teplyakov, A. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042589 · Cited by 3,604
Identification of a new human coronavirus
van der Hoek, L., Pyrc, K., Jebbink, M. F., Vermeulen-Oost, W., Berkhout, R. J. M., Wolthers, K. C., Wertheim-van Dillen, P. M. E., Kaandorp, J., Spaargaren, J., & Berkhout, B. (2004) · Nature Medicine · doi:10.1038/nm1024 · Cited by 1,886
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778
Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003) · Science · doi:10.1126/science.1085658 · Cited by 1,728
Self-citationAn introduction to data reduction: space-group determination, scaling and intensity statistics
Evans, P. R. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744491003982x · Cited by 1,485
Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835675100 · Cited by 990
Self-citationHu, B., Zeng, L.-P., Yang, X.-L., Ge, X.-Y., Zhang, W., Li, B., Xie, J.-Z., Shen, X.-R., Zhang, Y.-Z., Wang, N., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006698 · Cited by 950
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study
Xing, W., Liao, Q., Viboud, C., Zhang, J., Sun, J., Wu, J. T., Chang, Z., Liu, F., Fang, V. J., Zheng, Y., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70342-6 · Cited by 927
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Menachery, V. D., Yount, B. L., Debbink, K., Agnihothram, S., Gralinski, L. E., Plante, J. A., Graham, R. L., Scobey, T., Ge, X.-Y., Donaldson, E. F., et al. (2015) · Nature Medicine · doi:10.1038/nm.3985 · Cited by 901
A New Virus Isolated from the Human Respiratory Tract.
Hamre, D., & Procknow, J. J. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-121-30734 · Cited by 884
Ma, C., Sacco, M. D., Hurst, B., Townsend, J. A., Hu, Y., Szeto, T., Zhang, X., Tarbet, B., Marty, M. T., Chen, Y., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0356-z · Cited by 880
Self-citationde Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 736
Self-citationFrom SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
Hilgenfeld, R. (2014) · The FEBS Journal · doi:10.1111/febs.12936 · Cited by 660
Self-citationAnand, K. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf327 · Cited by 618
Snijder, E. J., van der Meer, Y., Zevenhoven-Dobbe, J., Onderwater, J. J. M., van der Meulen, J., Koerten, H. K., & Mommaas, A. M. (2006) · Journal of Virology · doi:10.1128/jvi.02501-05 · Cited by 512
Self-citationGorbalenya, A. E., Donchenko, A. P., Blinov, V. M., & Koonin, E. V. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80109-7 · Cited by 440
JLigand: a graphical tool for the CCP 4 template-restraint library
Lebedev, A. A., Young, P., Isupov, M. N., Moroz, O. V., Vagin, A. A., & Murshudov, G. N. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744491200251x · Cited by 429
Pfefferle, S., Schöpf, J., Kögl, M., Friedel, C. C., Müller, M. A., Carbajo-Lozoya, J., Stellberger, T., von Dall’Armi, E., Herzog, P., Kallies, S., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002331 · Cited by 415
Self-citationChang, L.-Y., Lin, T.-Y., Hsu, K.-H., Huang, Y.-C., Lin, K.-L., Hsueh, C., Shih, S.-R., Ning, H.-C., Hwang, M.-S., Wang, H.-S., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04434-7 · Cited by 402
Greninger, A. L., Naccache, S. N., Messacar, K., Clayton, A., Yu, G., Somasekar, S., Federman, S., Stryke, D., Anderson, C., Yagi, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70093-9 · Cited by 390
Kim, Y., Lovell, S., Tiew, K.-C., Mandadapu, S. R., Alliston, K. R., Battaile, K. P., Groutas, W. C., & Chang, K.-O. (2012) · Journal of Virology · doi:10.1128/jvi.01348-12 · Cited by 360
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
Hilgenfeld, R., & Peiris, M. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.015 · Cited by 354
Self-citationde Wilde, A. H., Raj, V. S., Oudshoorn, D., Bestebroer, T. M., van Nieuwkoop, S., Limpens, R. W. A. L., Posthuma, C. C., van der Meer, Y., Bárcena, M., Haagmans, B. L., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.052910-0 · Cited by 348
Self-citationXDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS
Krug, M., Weiss, M. S., Heinemann, U., & Mueller, U. (2012) · Journal of Applied Crystallography · doi:10.1107/s0021889812011715 · Cited by 306
Venkatraman, S., Bogen, S. L., Arasappan, A., Bennett, F., Chen, K., Jao, E., Liu, Y.-T., Lovey, R., Hendrata, S., Huang, Y., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060325b · Cited by 281
Xue, X., Yang, H., Shen, W., Zhao, Q., Li, J., Yang, K., Chen, C., Jin, Y., Bartlam, M., & Rao, Z. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.073 · Cited by 260
Yang, X.-L., Hu, B., Wang, B., Wang, M.-N., Zhang, Q., Zhang, W., Wu, L.-J., Ge, X.-Y., Zhang, Y.-Z., Daszak, P., et al. (2016) · Journal of Virology · doi:10.1128/jvi.02582-15 · Cited by 249
Kim, Y., Liu, H., Galasiti Kankanamalage, A. C., Weerasekara, S., Hua, D. H., Groutas, W. C., Chang, K.-O., & Pedersen, N. C. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005531 · Cited by 238
Self-citationHayden, F. G., Turner, R. B., Gwaltney, J. M., Chi-Burris, K., Gersten, M., Hsyu, P., Patick, A. K., Smith, G. J., & Zalman, L. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3907-3916.2003 · Cited by 231
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
Romano, K. P., Ali, A., Aydin, C., Soumana, D., Özen, A., Deveau, L. M., Silver, C., Cao, H., Newton, A., Petropoulos, C. J., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002832 · Cited by 219
Wang, F., Chen, C., Tan, W., Yang, K., & Yang, H. (2016) · Scientific Reports · doi:10.1038/srep22677 · Cited by 189
Tan, J., Verschueren, K. H. G., Anand, K., Shen, J., Yang, M., Xu, Y., Rao, Z., Bigalke, J., Heisen, B., Mesters, J. R., et al. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.012 · Cited by 184
Self-citationGBF1, a Guanine Nucleotide Exchange Factor for Arf, Is Crucial for Coxsackievirus B3 RNA Replication
Lanke, K. H. W., van der Schaar, H. M., Belov, G. A., Feng, Q., Duijsings, D., Jackson, C. L., Ehrenfeld, E., & van Kuppeveld, F. J. M. (2009) · Journal of Virology · doi:10.1128/jvi.01244-09 · Cited by 177
Wong, K. T., Munisamy, B., Ong, K. C., Kojima, H., Noriyo, N., Chua, K. B., Ong, B. B., & Nagashima, K. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318163a990 · Cited by 159
Binford, S. L., Maldonado, F., Brothers, M. A., Weady, P., Zalman, L. S., Meador, J. W., Matthews, D. A., & Patick, A. K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.619-626.2005 · Cited by 155
Lee, C., Kuo, C., Ko, T., Hsu, M.-F., Tsui, Y.-C., Chang, S., Yang, S., Chen, S.-J., Chen, H., Hsu, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807947200 · Cited by 143
Carbajo-Lozoya, J., Ma‐Lauer, Y., Malešević, M., Theuerkorn, M., Kahlert, V., Prell, E., von Brunn, B., Muth, D., Baumert, T. F., Drosten, C., et al. (2014) · Virus Research · doi:10.1016/j.virusres.2014.02.010 · Cited by 140
Eckerle, I., Müller, M. A., Kallies, S., Gotthardt, D. N., & Drosten, C. (2013) · Virology Journal · doi:10.1186/1743-422x-10-359 · Cited by 126
Zhu, L., George, S., Schmidt, M. F., Al‐Gharabli, S., Rademann, J., & Hilgenfeld, R. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.08.001 · Cited by 125
Self-citationLu, G., Qi, J., Chen, Z., Xu, X., Gao, F., Lin, D., Qian, W., Liu, H., Jiang, H., Yan, J., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00787-11 · Cited by 123
Self-citationKusov, Y., Tan, J., Álvarez, E. A., Enjuanes, L., & Hilgenfeld, R. (2015) · Virology · doi:10.1016/j.virol.2015.06.016 · Cited by 122
Self-citationTan, J., George, S., Kusov, Y., Perbandt, M., Anemüller, S., Mesters, J. R., Norder, H., Coutard, B., Lacroix, C., Leyssen, P., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01123-12 · Cited by 122
Self-citationSchultz, D. E., Honda, M., Whetter, L. E., McKnight, K. L., & Lemon, S. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1041-1049.1996 · Cited by 93
Chan, J. F., Choi, G. K.-Y., Tsang, A. K. L., Tee, K., Lam, H., Yip, C. C., To, K. K., Cheng, V. C., Yeung, M. L., Lau, S. K. P., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01224-15 · Cited by 93
Enterovirus D68. A Focused Review and Clinical Highlights from the 2014 U.S. Outbreak
Oermann, C. M., Schuster, J. E., Conners, G. P., Newland, J. G., Selvarangan, R., & Jackson, M. A. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201412-592fr · Cited by 91
Verschueren, K. H. G., Pumpor, K., Anemüller, S., Chen, S., Mesters, J. R., & Hilgenfeld, R. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.04.011 · Cited by 86
Self-citationvan Kuppeveld, F. J. M., Galama, J. M. D., Zoll, J., & Melchers, W. J. G. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7782-7790.1995 · Cited by 80
Liang, J. J., Pitsillou, E., Karagiannis, C., Darmawan, K. K., Ng, K., Hung, A., & Karagiannis, T. C. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107292 · Cited by 68
Bafna, K., Cioffi, C. L., Krug, R. M., & Montelione, G. T. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.948553 · Cited by 68
Potent inhibition of norovirus 3CL protease by peptidyl α-ketoamides and α-ketoheterocycles
Mandadapu, S. R., Weerawarna, P. M., Gunnam, M. R., Alliston, K. R., Lushington, G. H., Kim, Y., Chang, K., & Groutas, W. C. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.05.055 · Cited by 61
Maurya, S., Maurya, A. K., Mishra, N., & Siddique, H. R. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1772298 · Cited by 61
Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors
Prior, A. M., Kim, Y., Weerasekara, S., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.070 · Cited by 60
Intricacies of cardiac damage in coxsackievirus B3 infection: Implications for therapy
Massilamany, C., Gangaplara, A., & Reddy, J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.136 · Cited by 52
Lee, J., & Storch, G. A. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000292 · Cited by 48
Qian, J., Cuerrier, D., Davies, P. L., Li, Z., Powers, J. C., & Campbell, R. L. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800045t · Cited by 45
Dragovich, P. S. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00005-x · Cited by 43
The Differential Clinical Impact of Human Coronavirus Species in Children With Cystic Fibrosis
Filho, L. V. R. F. D. S., Zerbinati, R. M., Tateno, A., Boas, L. V., de Almeida, M. B., Levi, J. E., Drexler, J. F., Drosten, C., & Pannuti, C. M. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis274 · Cited by 33
Potent inhibition of enterovirus D68 and human rhinoviruses by dipeptidyl aldehydes and α-ketoamides
Kim, Y., Kankanamalage, A. C. G., Damalanka, V. C., Weerawarna, P. M., Groutas, W. C., & Chang, K. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.11.010 · Cited by 32
South Korean MERS outbreak spotlights lack of research
Butler, D. (2015) · Nature · doi:10.1038/522139a · Cited by 23
Rhinovirus-induced asthma exacerbations and risk populations
Coleman, L. A., Laing, I. A., & Bosco, A. (2016) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000245 · Cited by 9
(1982) · PubMed
Cited by
Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020) · Science · doi:10.1126/science.abb3405 · Cited by 2,895
Self-citationAn oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
Owen, D. R., Allerton, C. M. N., Anderson, A. S., Aschenbrenner, L., Avery, M., Berritt, S., Boras, B., Cardin, R. D., Carlo, A., Coffman, K. J., et al. (2021) · Science · doi:10.1126/science.abl4784 · Cited by 2,033
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., et al. (2020) · Science · doi:10.1126/science.abb4489 · Cited by 1,478
Self-citationMa, C., Sacco, M. D., Hurst, B., Townsend, J. A., Hu, Y., Szeto, T., Zhang, X., Tarbet, B., Marty, M. T., Chen, Y., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0356-z · Cited by 880
Self-citationThe SARS-CoV-2 main protease as drug target
Ullrich, S., & Nitsche, C. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127377 · Cited by 772
Metadata
- Authors
- Zhang, L., Lin, D., Kusov, Y., Nian, Y., Ma, Q., Wang, J., von Brunn, A., Leyssen, P., Lanko, K., Neyts, J., de Wilde, A., Snijder, E. J., Liu, H., & Hilgenfeld, R.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-02-11
- Volume
- 63
- Issue
- 9
- Pages
- 4562-4578
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3005775246
- Cited by
- 568
- References
- 67
- FWCI
- 13.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.